Fig. 1: Magnetic resonance and amyloid-PET (18F-Florbetapen) images—case 3. | Nature Medicine

Fig. 1: Magnetic resonance and amyloid-PET (18F-Florbetapen) images—case 3.

From: Iatrogenic Alzheimer’s disease in recipients of cadaveric pituitary-derived growth hormone

Fig. 1

a, High-resolution three-dimensional (3D) T1-weighted (T1W) magnetic resonance (MR) coronal image through the temporal lobes demonstrates volume loss within the temporal lobes bilaterally (arrows) and also marked central atrophy. b, Axial PET images demonstrate diffuse increased tracer uptake in the cortex and subcortical white matter, increased in the right temporal lobe compared to the left. c, High-resolution MR (3D T1W) coronal image through superior parietal lobules bilaterally demonstrates marked volume loss (arrows). d, Axial PET images demonstrate marked tracer uptake within the superior parietal lobules bilaterally (arrows) in addition to increased uptake in the bilateral frontal lobes (arrowheads).

Back to article page